J Infect Dis. 1999 Sep;180(3):621-5.

Progressive multifocal leukoencephalopathy: improved survival of human immunodeficiency virus-infected patients in the protease inhibitor era.

Dworkin MS, Wan PC, Hanson DL, Jones JL.

Source

Division of HIV/AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. mdd3@cdc.gov

Abstract

To examine factors affecting survival after diagnosis of progressive multifocal leukoencephalopathy (PML), we analyzed data from an observational cohort study, the Adult and Adolescent Spectrum of HIV Disease project. We identified 415 patients diagnosed with PML during 1990-1997. The median survival time after diagnosis was 1 month. By use of an extended proportional hazards, multivariate regression model, risk factors associated with decreased survival time included CD4 count <0.20 x 10(9) cells/L (risk ratio [RR], 2.1; 95% confidence interval [CI], 1.3-3.5) compared with >/=0.20 x 10(9) cells/L, whereas factors associated with increased survival time were prescription of antiretroviral medication that contained a protease inhibitor (RR, 0.2; 95% CI, 0.1-0.4) and prescription of other antiretroviral medication (RR, 0.6; 95% CI, 0.5-0.8) compared with no antiretroviral prescription. We conclude that protease inhibitor use (in combination antiretroviral therapy) is likely to favorably affect survival time after diagnosis of PML.

PMID:: 10438348; [PubMed - indexed for MEDLINE]

Free full text

MeSH Terms, Substances

MeSH Terms

Substances

HIV Protease Inhibitors

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Medical

Supplemental Content

Related citations

Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study. [J Infect Dis. 2009]
Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study.
Engsig FN, Hansen AB, Omland LH, Kronborg G, Gerstoft J, Laursen AL, Pedersen C, Mogensen CB, Nielsen L, Obel N. J Infect Dis. 2009 Jan 1; 199(1):77-83.
Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study. [Clin Infect Dis. 2009]
Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study.
Khanna N, Elzi L, Mueller NJ, Garzoni C, Cavassini M, Fux CA, Vernazza P, Bernasconi E, Battegay M, Hirsch HH, et al. Clin Infect Dis. 2009 May 15; 48(10):1459-66.
Survival improvement of AIDS-related progressive multifocal leukoencephalopathy in the era of protease inhibitors. Clinical Epidemiology Group. French Hospital Database on HIV. [AIDS. 1999]
Survival improvement of AIDS-related progressive multifocal leukoencephalopathy in the era of protease inhibitors. Clinical Epidemiology Group. French Hospital Database on HIV.
Tassie JM, Gasnault J, Bentata M, Deloumeaux J, Boué F, Billaud E, Costagliola D. AIDS. 1999 Oct 1; 13(14):1881-7.
Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings. [Antivir Ther. 2003]
Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
Bedell R, Heath KV, Hogg RS, Wood E, Press N, Yip B, O'Shaughnessy MV, Montaner JS. Antivir Ther. 2003 Oct; 8(5):379-84.
Review Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. [Lancet. 2009]
Review Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.
When To Start Consortium, Sterne JA, May M, Costagliola D, de Wolf F, Phillips AN, Harris R, Funk MJ, Geskus RB, Gill J, et al. Lancet. 2009 Apr 18; 373(9672):1352-63. Epub 2009 Apr 8.

See reviews... See all...

Cited by 2 PubMed Central articles

Determinants of survival in progressive multifocal leukoencephalopathy. [Neurology. 2009]
Determinants of survival in progressive multifocal leukoencephalopathy.
Marzocchetti A, Tompkins T, Clifford DB, Gandhi RT, Kesari S, Berger JR, Simpson DM, Prosperi M, De Luca A, Koralnik IJ. Neurology. 2009 Nov 10; 73(19):1551-8.
Microarray analysis of glial cells resistant to JCV infection suggests a correlation between viral infection and inflammatory cytokine gene expression. [Virology. 2007]
Microarray analysis of glial cells resistant to JCV infection suggests a correlation between viral infection and inflammatory cytokine gene expression.
Manley K, Gee GV, Simkevich CP, Sedivy JM, Atwood WJ. Virology. 2007 Sep 30; 366(2):394-404. Epub 2007 Jun 6.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Progressive multifocal leukoencephalopathy: improved survival of human immunodef...
Progressive multifocal leukoencephalopathy: improved survival of human immunodeficiency virus-infected patients in the protease inhibitor era.
J Infect Dis. 1999 Sep ;180(3):621-5.

PubMed
Association studies of transforming growth factor-beta 1 and Alzheimer's disease...
Association studies of transforming growth factor-beta 1 and Alzheimer's disease.
Am J Med Genet B Neuropsychiatr Genet. 2005 Nov 5 ;139B(1):38-41.

PubMed
Stressful experiences in children and adolescents: initial report from the PSEI-...
Stressful experiences in children and adolescents: initial report from the PSEI-NCPV Honolulu Study.
Hawaii Med J. 2003 Mar ;62(3):53-8.

PubMed
Alpha-lipoic acid suppresses osteoclastogenesis despite increasing the receptor ...
Alpha-lipoic acid suppresses osteoclastogenesis despite increasing the receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio in human bone marrow stromal cells.
J Endocrinol. 2005 Jun ;185(3):401-13.

PubMed
Steroid-responsive encephalopathy associated with autoimmune thyroiditis.
Steroid-responsive encephalopathy associated with autoimmune thyroiditis.
Arch Neurol. 2006 Feb ;63(2):197-202.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: